Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.

by Géraldine H Petit, Elijahu Berkovich, Mark Hickery, Pekka Kallunki, Karina Fog, Cheryl Fitzer-Attas, Patrik Brundin
Published 2013-01-01

Revisiting the Logan plot to account for non-negligible blood volume in brain tissue

by Martin Schain, Patrik Fazio, Ladislav Mrzljak, Nahid Amini, Nabil Al-Tawil, Cheryl Fitzer-Attas, Juliana Bronzova, Bernhard Landwehrmeyer, Christina Sampaio, Christer Halldin, Andrea Varrone
Published 2017-08-01

Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

by Alan Godfrey, Benjamin Vandendriessche, Jessie P. Bakker, Cheryl Fitzer‐Attas, Ninad Gujar, Matthew Hobbs, Qi Liu, Carrie A. Northcott, Virginia Parks, William A. Wood, Vadim Zipunnikov, John A. Wagner, Elena S. Izmailova
Published 2021-01-01

Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)

by Jennifer C. Goldsack, Andrea Coravos, Jessie P. Bakker, Brinnae Bent, Ariel V. Dowling, Cheryl Fitzer-Attas, Alan Godfrey, Job G. Godino, Ninad Gujar, Elena Izmailova, Christine Manta, Barry Peterson, Benjamin Vandendriessche, William A. Wood, Ke Will Wang, Jessilyn Dunn
Published 2020-04-01